Valuation: Middle East Pharmaceutical Industries Company

Market Cap 2.05B 547M 481M 448M 411M 772M 52.49B 783M 5.32B 2.08B 25.92B 2.01B 89.58B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.08B 555M 488M 454M 417M 783M 53.24B 794M 5.4B 2.11B 26.29B 2.04B 90.86B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
46.88%
Yield 2024
1.64%
Yield 2025 2.18%
1 day-1.59%
1 week-2.17%
Current month-2.98%
1 month-2.17%
3 months-1.32%
6 months-8.77%
Current year-7.62%
1 week 58.5
Extreme 58.5
60.8
1 month 58.35
Extreme 58.35
64.5
Current year 53.89
Extreme 53.8857
68.51
1 year 53.89
Extreme 53.8857
79.09
3 years 51.54
Extreme 51.5429
112.91
5 years 51.54
Extreme 51.5429
112.91
10 years 51.54
Extreme 51.5429
112.91
Manager TitleAgeSince
Chief Executive Officer 45 05/09/2018
Director of Finance/CFO - 11/03/2024
Chief Tech/Sci/R&D Officer 51 01/01/2023
Director TitleAgeSince
Chairman 54 10/04/2022
Director/Board Member 45 13/09/2023
Director/Board Member 45 10/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
-1.59%-2.17%-11.67% - 556M
+1.68%+2.13%+16.17%+77.49% 48.36B
+1.52%+2.95%+60.39%+112.28% 35.8B
-0.09%-0.66%-8.03%+31.90% 11.83B
-0.05%-3.10%+13.50%+77.95% 11.48B
+0.56%-0.37%+37.53%+142.08% 9.01B
+0.18%+0.58%+49.62%-9.13% 6.99B
+0.95%-2.00%+12.78%+32.58% 6.7B
+0.18%-1.77%+2.36%+172.36% 6.42B
+3.51%-10.57%-31.55%+0.09% 5.3B
Average +0.68%-1.15%+14.11%+70.85% 14.25B
Weighted average by Cap. +1.16%-0.15%+25.38%+81.62%

Financials

2024 2025
Net sales 394M 105M 92.27M 85.89M 78.88M 148M 10.07B 150M 1.02B 399M 4.97B 386M 17.18B 460M 123M 108M 100M 92.19M 173M 11.76B 175M 1.19B 466M 5.81B 451M 20.08B
Net income 79.85M 21.27M 18.7M 17.41M 15.99M 30.02M 2.04B 30.41M 207M 80.81M 1.01B 78.13M 3.48B 97.01M 25.84M 22.72M 21.15M 19.42M 36.47M 2.48B 36.95M 251M 98.17M 1.22B 94.92M 4.23B
Net Debt 42.83M 11.41M 10.03M 9.34M 8.57M 16.1M 1.09B 16.31M 111M 43.35M 540M 41.91M 1.87B 29.47M 7.85M 6.9M 6.43M 5.9M 11.08M 753M 11.23M 76.37M 29.83M 372M 28.84M 1.29B
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
27/07/26 SAR 58.70 -1.59% 43,252
26/07/26 SAR 59.65 -0.25% 17,780
23/07/26 SAR 59.80 -0.33% 38,361
22/07/26 SAR 60.00 +0.42% 23,215
21/07/26 SAR 59.75 -1.32% 37,356
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
58.70SAR
Average target price
83.66SAR
Spread / Average Target
+42.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4016 Stock